Ciba Vision/Presby Corp.
This article was originally published in The Gray Sheet
Executive Summary
Exclusive worldwide license is granted to Ciba Vision to manufacture and market Presby's scleral expansion implants and specialized automated incision device for presbyopia, ocular hypertension and primary open angle glaucoma. Ciba will provide additional cash infusions to Presby in conjunction with future milestones, including FDA approval for glaucoma and presbyopia, expected in two and three years, respectively. Ciba Vision anticipates a launch in Europe and Canada later this year...